Reply: Is thymidylate synthase a reliable predictor for response and survival during hepatic arterial infusion for hepatic metastasis from colorectal cancer
暂无分享,去创建一个
[1] G. Watanabe,et al. Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] C. Wittmer,et al. Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS) – novel predictors for response and survival in gastric cancer patients , 2005, British Journal of Cancer.
[3] P. Goodfellow,et al. Concordance of pharmacogenetic markers in germline and colorectal tumor DNA. , 2005, Pharmacogenomics.
[4] A. Jakobsen,et al. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] S. Groshen,et al. A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer , 2004, British Journal of Cancer.